US Patent Issued to Regeneron Pharmaceuticals on Nov. 11 for "NY-ESO-1 T cell receptors and methods of use thereof" (New Jersey, New York, Connecticut Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,870, issued on Nov. 11, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"NY-ESO-1 T cell receptors and methods of use thereof" was invented by Robert Babb (River Edge, N.J.), Natalie Bowerman (Stamford, Conn.), Gang Chen (Yorktown Heights, N.Y.), Cagan Gurer (Chappaqua, N.Y.), Johanna Hansen (Greenwich, Conn.), Wen-Yi Lee (New Hyde Park, N.Y.), Thomas Meagher (Yorktown Heights, N.Y.) and David Suh (Midland Park, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides isolated T cell receptors (TCRs) that specifically bind to an HLA-displayed New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1) peptide...